Endovascular treatment of superficial femoral and popliteal arterial occlusive disease

Journal of Invasive Cardiology

Volumn 12, Issue 7, 2000, Pages 382-388

  Ansel, Gary M ^a,b  

^a MidWest Cardiology Research Foundation   (United States)

^b MidOhio Cardiology and Vascular Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ANGIOPLASTY; FEMORAL ARTERY; HUMAN; METHODOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; RADIOGRAPHY; REVIEW; TREATMENT OUTCOME;

ANGIOGRAPHY; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; FEMORAL ARTERY; HUMANS; POPLITEAL ARTERY; TREATMENT OUTCOME;

EID: 0034220433     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Weitz JL, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation 1996;94:3026-3049.
2. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality: The Whitehall study. Circulation 1990;82:1925-1931.
3. Newman AB, Siscovick DS, Manolio TA, et al. Ankle/arm index as a marker of atherosclerosis in the cardiovascular health study. Circulation 1993;88:837-845.
4. Ernst E, Fialka V. A review of the clinical effectiveness of exercise therapy for intermittent claudication: Indications, methods, and results. Surgery 1978;84:640-643.
5. Ekroth R, Dahllof AG, M Gundevall D, et al. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg 1997;25:312-319.
6. Dawson DL, Cutler BS, Meissner MH, Strandness DE. Cilostazol has beneficial effects in treatment of intermittent claudication. Circulation 1998;98:678-686.
7. Veith FJ, Gupta SK, Ascer E, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetraflouroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-114.
8. Michaels JA. Choice of material for above-knee femoropopliteal bypass graft. Br J Surg 1989;76:7-14.
9. Byrne J, Darling RC, Chang BB, et al. Infrainguinal arterial reconstruction for claudication: Is it worth the risk? An analysis of 409 procedures. J Vasc Surg 1999;29:259-267.
10. Applegate WB. Ankle/arm blood pressure index: A useful test for clinical practice? JAMA 1993;270:497-498.
11. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-386.
12. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia. J Vasc Surg 1997;26:517-518.
13. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty, factors influencing long-term success. Circulation 1991;83:I70-I80.
14. Johnston KW. Femoral and popliteal arteries: Re-analysis of results of balloon angioplasty. Radiology 1992;183:767-771.
15. Matsi PJ, Manninen HI, Vanninen RL, et al. Femoropopliteal angioplasty in patients with claudication: Primary and secondary patency in 140 limbs with 1-3 year follow-up. Radiology 1994;191:727-733.
16. Cheng SW, Ting AC, Lau H, Wong J. Immediate stenting of iliofemoral occlusive lesions: A surgeon's early experiences. J Endovasc Surg 1999;6:256-263.
17. Cooper JC, Weish CL. Percutaneous transluminal angioplasty in the treatment of femoropopliteal occlusion treated with percutaneous transluminal angioplasty. Eur J Vasc Surg 1990;4:149-152.
18. Krepel VM, Van Andel GJ, Van Erp WF, Breslau PJ. Percutaneous transluminal angioplasty of the femoropopliteal artery: Initial and long-term results. Radiology 1985;156:325-328.
19. Murray JG, Apthrop LA, Wilkins RA. Long-segment (> 10 cm) femoropopliteal angioplasty: Improved technical success ' and long-term patency. Radiology 1995;195:158-162.
20. Mewissen MW, Kinnery EV, Bandyk DF, et al. The role of duplex scanning versus angiography in predicting outcome after balloon angioplasty in the femoropopliteal artery. J Vasc Surg 1992;15:860-865.
21. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction: Description of a new technique and a preliminary report of its application. Circulation 1964;30:654-670.
22. Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: A 5-year follow-up. Circulation 1984;70:619-623.
23. Johnston KW. Femoral and popliteal arteries: Re-analysis of results of balloon angioplasty. Radiology 1992;183:767-771.
24. Henry M, Amor M, Ethevenor G, et al. Palmaz stent placement in iliac and femoropopliteal arteries: Primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology 1995;197:167-174.
25. Gray BH, Olin JW. Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease. Semin Vasc Surg 1997;10:8-16.
26. Rousseau HP, Raillat CR, Joffre FH, et al. Treatment of femoropopliteal stenoses by means of self-expandable endoprostheses: Midterm results. Radiology 1989;172:961-964.
27. Rosenfield K, Schainfeld R, Pieczek A, et al. Restenosis of endovascular stents due to stent compression. J Am Coll Cardiol 1997;29:321-338.
28. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998;339:1667-1671.
29. Gray BH, Sullivan TM, Childs MB, et al. High-incidence of restenosis/occlusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997;25:74-83.
30. Ansel GM, Yakubov S, Tugaeon J, Kander NH. Successful limb salvage with superficial femoral Wallstenting. Circulation 96(Suppl):755.
31. Chatelard P, Gurbourt C. Long-term results with a Palmaz stent in the femoropopliteal arteries. J Cardiovasc Surg 1996;37:67-72.
32. Henry M, Amor M, Berger R, et al. Clinical experience with a new Nitinol self-expanding stent peripheral arteries. J Endovasc Surg 1996;3:369-379.
33. Ansel GM, George B, Botti C, Noethen A. Clinical outcomes of rotational atherectomy for in-stent restenosis of superficial femoral and popliteal arteries. Am J Cardiol 1999;84:42.
34. Biamino G, Regg JC, Streak B, et al. Long occlusions of the superficial femoral artery: Success rate and 1-year follow-up after Excimer laser-assisted angioplasty. Eur Heart J 1994;14:147.
35. Diethrich EB, Papzoglou K. Endoluminal grafting for aneurismal and occlusive disease in the superficial femoral artery: Early experience. J Endovasc Surg 1995;2:225-239.
36. Liermann D, Kirchner J, Beuernsachs R, et al. Brachytherapy with iridium-192 HDR to prevent restenosis in peripheral arteries: An update. Herz 1998;23:394-400.
37. Spoelstra H, Casselman F, Lesceu O. Balloon-expandable endobypass for femoropopliteal atherosclerotic occlusive disease. J Vasc Surg 1996;24:647-654.
38. Strecker EP, Gottmannd, Boos IB, Vetter S. Low-molecular-weight heparin (reviparin) reduces the incidence of femoropopliteal in-stent stenosis: Preliminary results of an ongoing study. Cardiovasc Intervent Radiol 1998;29:375-379.
39. Yamaski M, Hara K, Ikari Y, Kobayashi N. Effects of Cilostazol on late lumen loss after Palmaz-Schatz stent implantation. Cathet Cardiovasc Diagn 1998;44:387-391.